Physiomics Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Physiomics.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Life Sciences earnings growth	19.8%
Revenue growth rate	n/a
Future return on equity	n/a
Analyst coverage	Low
Last updated	27 Sep 2024

Recent future growth updates

Recent updates

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Nov 15

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Nov 17

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Nov 16

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

Feb 08

Earnings and Revenue Growth Forecasts

AIM:PYC - Analysts future estimates and past financials data (GBP Millions)
Date	Revenue	Earnings	Free Cash Flow	Cash from Op	Avg. No. Analysts
6/30/2025	1	-1	N/A	-1	1
6/30/2024	1	-1	-1	-1	N/A
3/31/2024	1	-1	-1	0	N/A
12/31/2023	1	0	0	0	N/A
9/30/2023	1	0	0	0	N/A
6/30/2023	1	0	0	0	N/A
3/31/2023	1	0	0	0	N/A
12/31/2022	1	0	0	0	N/A
9/30/2022	1	0	0	0	N/A
6/30/2022	1	0	0	0	N/A
3/31/2022	1	0	0	0	N/A
12/31/2021	1	0	0	0	N/A
9/30/2021	1	0	0	0	N/A
6/30/2021	1	0	0	0	N/A
3/31/2021	1	0	0	0	N/A
12/31/2020	1	0	0	0	N/A
9/30/2020	1	0	0	0	N/A
6/30/2020	1	0	0	0	N/A
3/31/2020	1	0	0	0	N/A
12/31/2019	1	0	0	0	N/A
9/30/2019	1	0	0	0	N/A
6/30/2019	1	0	0	0	N/A
3/31/2019	1	0	0	0	N/A
12/31/2018	1	0	0	0	N/A
9/30/2018	1	0	0	0	N/A
6/30/2018	1	0	0	0	N/A
3/31/2018	0	0	N/A	0	N/A
12/31/2017	0	0	N/A	0	N/A
9/30/2017	0	0	N/A	0	N/A
6/30/2017	0	0	N/A	0	N/A
3/31/2017	0	0	N/A	0	N/A
12/31/2016	0	0	N/A	0	N/A
9/30/2016	0	0	N/A	0	N/A
6/30/2016	0	0	N/A	0	N/A
3/31/2016	0	0	N/A	0	N/A
12/31/2015	0	0	N/A	0	N/A
9/30/2015	0	0	N/A	0	N/A
6/30/2015	0	0	N/A	0	N/A
3/31/2015	0	0	N/A	0	N/A
12/31/2014	0	0	N/A	0	N/A
9/30/2014	0	0	N/A	0	N/A
6/30/2014	0	0	N/A	0	N/A
3/31/2014	0	0	N/A	0	N/A
12/31/2013	0	0	N/A	-1	N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if PYC's forecast earnings growth is above the savings rate (1.9%).

Earnings vs Market: Insufficient data to determine if PYC's earnings are forecast to grow faster than the UK market

High Growth Earnings: Insufficient data to determine if PYC's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if PYC's revenue is forecast to grow faster than the UK market.

High Growth Revenue: Insufficient data to determine if PYC's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if PYC's Return on Equity is forecast to be high in 3 years time

Physiomics Future Growth

Future criteria checks 0/6

Key information

Recent future growth updates

Physiomics Plc Increases Revenue Expectation for the Year 2025

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

Recent updates

Physiomics plc Appoints Dr. Mark Davies as Head of Quantitative Pharmacology and Data Science

Physiomics Plc, Annual General Meeting, Nov 19, 2024

Full year 2024 earnings: Revenues miss analyst expectations

New minor risk - Financial data availability

New major risk - Shareholder dilution

Dr. Christophe Chassagnole Step Down as Director and as Chief Scientific Officer of Physiomics plc

Physiomics Plc Increases Revenue Expectation for the Year 2025

First half 2024 earnings released: UK£0.002 loss per share (vs UK£0.002 loss in 1H 2023)

Physiomics Plc to Report First Half, 2024 Results on Mar 07, 2024

New minor risk - Shareholder dilution

Less than half of directors are independent

Physiomics plc Announces Chief Executive Officer Changes

It's Unlikely That Shareholders Will Increase Physiomics Plc's (LON:PYC) Compensation By Much This Year

Physiomics Plc, Annual General Meeting, Nov 21, 2023

Physiomics Plc Appoints Dr Venkata Putcha, as Head of Biostatistics

Full year 2023 earnings: EPS in line with expectations, revenues disappoint

New minor risk - Financial data availability

New minor risk - Financial data availability

Physiomics plc Appoints Dr. Peter Sargent as Chief Operating Officer

New minor risk - Shareholder dilution

First half 2023 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in 1H 2022)

Physiomics plc Announces Change of Job Title of Dr. Christophe Chassagnole from Chief Operating Officer to Chief Scientific Officer

Physiomics Plc Announces Successful Completion of its PARTNER Study

Here's Why We Think Physiomics Plc's (LON:PYC) CEO Compensation Looks Fair

Full year 2022 earnings: EPS and revenues exceed analyst expectations

Physiomics Plc, Annual General Meeting, Nov 22, 2022

Third quarter 2022 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 3Q 2021)

Physiomics Plc to Report Fiscal Year 2022 Results on Sep 29, 2022

Physiomics Plc Appoints Shalabh Kumar as Independent Non-Executive Director

Less than half of directors are independent

Physiomics plc Announces Board Changes, Effective April 1, 2022

First half 2022 earnings: EPS exceeds analyst expectations while revenues lag behind

Physiomics Plc to Report First Half, 2022 Results on Mar 07, 2022

Physiomics plc Announces Board Changes

Here's Why Shareholders Will Not Be Complaining About Physiomics Plc's (LON:PYC) CEO Pay Packet

Full year 2021 earnings released: UK£0.002 loss per share (vs UK£0.001 loss in FY 2020)

Physiomics plc Announces Earnings Guidance for the Year Ending June 30, 2021

First half 2021 earnings released: UK£0.001 loss per share (vs UK£0.001 loss in 1H 2020)

What Can We Conclude About Physiomics' (LON:PYC) CEO Pay?

TRHC’s DoseMeRx Partners with Physiomics to Provide Precision Dosing for Oncology Medications

Physiomics Plc Announces Approval of NIHR-funded PARTNER Study

Full year earnings released - UK£0.00087 loss per share

Annual earnings released: Earnings beat expectations, revenue disappoints

Physiomics plc Receives Award from Bicycle Therapeutics plc and Merck KGaA to Further Contracts of Undisclosed Value for Projects

Full year earnings released - UK£0.00087 loss per share

Physiomics Plc to Report Fiscal Year 2020 Results on Sep 30, 2020

Earnings and Revenue Growth Forecasts

Analyst Future Growth Forecasts

Earnings per Share Growth Forecasts

Future Return on Equity

Discover growth companies